New
Image

11.08.2025
86% of people with type 1 and 75% of people with type 2 experience jud...
Our new stigma research looks at diabetes stigma at scale across the UK. With blame, shame and stigma sta...
customer support
customer support
We take a look at some of the exciting diabetes research developments announced in July, including how teplizumab targets type 1 diabetes and understanding the risk of eating disorders for people taking part in type 2 diabetes remission programmes.
Read more